These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 27987324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice.
    Wu X, Liu C, Chen L, Du YF, Hu M, Reed MN, Long Y, Suppiramaniam V, Hong H, Tang SS.
    Int Immunopharmacol; 2019 Jul; 72():166-175. PubMed ID: 30986644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway.
    Qi YC, Duan GZ, Mao W, Liu Q, Zhang YL, Li PF.
    Chin J Nat Med; 2020 Dec; 18(12):898-906. PubMed ID: 33357720
    [Abstract] [Full Text] [Related]

  • 9. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
    Högenauer K, Arista L, Schmiedeberg N, Werner G, Jaksche H, Bouhelal R, Nguyen DG, Bhat BG, Raad L, Rauld C, Carballido JM.
    J Med Chem; 2014 Dec 26; 57(24):10343-54. PubMed ID: 25411721
    [Abstract] [Full Text] [Related]

  • 10. INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis.
    Jin P, Deng S, Tian M, Lenahan C, Wei P, Wang Y, Tan J, Wen H, Zhao F, Gao Y, Gong Y.
    Exp Neurol; 2021 Jan 26; 335():113504. PubMed ID: 33058889
    [Abstract] [Full Text] [Related]

  • 11. 3,3'-Diindolylmethane inhibits lipopolysaccharide-induced microglial hyperactivation and attenuates brain inflammation.
    Kim HW, Kim J, Kim J, Lee S, Choi BR, Han JS, Lee KW, Lee HJ.
    Toxicol Sci; 2014 Jan 26; 137(1):158-67. PubMed ID: 24162184
    [Abstract] [Full Text] [Related]

  • 12. A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.
    Lewis ND, Patnaude LA, Pelletier J, Souza DJ, Lukas SM, King FJ, Hill JD, Stefanopoulos DE, Ryan K, Desai S, Skow D, Kauschke SG, Broermann A, Kuzmich D, Harcken C, Hickey ER, Modis LK.
    PLoS One; 2014 Jan 26; 9(6):e100883. PubMed ID: 24967665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
    Wimmer R, Hohenester S, Pusl T, Denk GU, Rust C, Beuers U.
    Gut; 2008 Oct 26; 57(10):1448-54. PubMed ID: 18583398
    [Abstract] [Full Text] [Related]

  • 15. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.
    Bhargava P, Smith MD, Mische L, Harrington E, Fitzgerald KC, Martin K, Kim S, Reyes AA, Gonzalez-Cardona J, Volsko C, Tripathi A, Singh S, Varanasi K, Lord HN, Meyers K, Taylor M, Gharagozloo M, Sotirchos ES, Nourbakhsh B, Dutta R, Mowry EM, Waubant E, Calabresi PA.
    J Clin Invest; 2020 Jul 01; 130(7):3467-3482. PubMed ID: 32182223
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation.
    Yanguas-Casás N, Barreda-Manso MA, Pérez-Rial S, Nieto-Sampedro M, Romero-Ramírez L.
    Mol Neurobiol; 2017 Nov 01; 54(9):6737-6749. PubMed ID: 27744574
    [Abstract] [Full Text] [Related]

  • 18. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.
    Qi Y, Shi L, Duan G, Ma Y, Li P.
    Molecules; 2021 Nov 23; 26(23):. PubMed ID: 34885648
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?
    Gronbeck KR, Rodrigues CM, Mahmoudi J, Bershad EM, Ling G, Bachour SP, Divani AA.
    Neurocrit Care; 2016 Aug 23; 25(1):153-66. PubMed ID: 26759227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.